ZA200801351B - Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors - Google Patents

Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors

Info

Publication number
ZA200801351B
ZA200801351B ZA200801351A ZA200801351A ZA200801351B ZA 200801351 B ZA200801351 B ZA 200801351B ZA 200801351 A ZA200801351 A ZA 200801351A ZA 200801351 A ZA200801351 A ZA 200801351A ZA 200801351 B ZA200801351 B ZA 200801351B
Authority
ZA
South Africa
Prior art keywords
sulphonypyrrole
histone deacetylases
hydrochloride salts
deacetylases inhibitors
inhibitors
Prior art date
Application number
ZA200801351A
Other languages
English (en)
Inventor
Maier Thomas
Beckers Thomas
Hummel Rolf-Peter
Feth Martin
Mueller Matthias
Baer Thomas
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of ZA200801351B publication Critical patent/ZA200801351B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200801351A 2005-09-21 2008-02-08 Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors ZA200801351B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05108716 2005-09-21

Publications (1)

Publication Number Publication Date
ZA200801351B true ZA200801351B (en) 2009-09-30

Family

ID=35810290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801351A ZA200801351B (en) 2005-09-21 2008-02-08 Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors

Country Status (16)

Country Link
US (1) US8188138B2 (xx)
EP (1) EP1928826B1 (xx)
JP (1) JP5305909B2 (xx)
KR (1) KR101314158B1 (xx)
CN (1) CN101287706A (xx)
AR (1) AR055647A1 (xx)
AU (1) AU2006298881A1 (xx)
BR (1) BRPI0616040A2 (xx)
CA (1) CA2622670A1 (xx)
EA (1) EA018698B1 (xx)
IL (1) IL189781A0 (xx)
NO (1) NO20081796L (xx)
NZ (1) NZ566073A (xx)
TW (1) TWI382971B (xx)
WO (1) WO2007039403A1 (xx)
ZA (1) ZA200801351B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144144A0 (en) 1999-01-13 2002-05-23 Bayer Ag Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
CA2475703C (en) 2002-02-11 2016-12-20 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
US20070020704A1 (en) 2003-05-20 2007-01-25 Scott Wilhelm Diaryl ureas with kinase inhibiting activity
JP4856623B2 (ja) * 2004-03-11 2012-01-18 フォーエスシー アクチエンゲゼルシャフト 新規のｎ−スルホニルピロール誘導体
EP1751139B1 (en) 2004-04-30 2011-07-27 Bayer HealthCare LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer
WO2007039404A1 (en) * 2005-09-21 2007-04-12 Nycomed Gmbh Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles
WO2008127659A2 (en) * 2007-04-13 2008-10-23 University Of Texas Southwestern Medical Center Combination therapy for cancer
EP2100878A1 (en) 2008-03-12 2009-09-16 4Sc Ag Novel method for the production of sulphonylpyrroles as HDAC inhibitors
EP2100882A1 (en) * 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
ES2620027T3 (es) 2008-09-03 2017-06-27 Biomarin Pharmaceutical Inc. Composiciones que incluyen derivados del ácido 6-aminohexanoico como inhibidores de HDAC
US9540395B2 (en) 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2013154870A1 (en) 2012-04-10 2013-10-17 Annji Pharmaceutical Co., Ltd. Histone deacetylases (hdacs) inhibitors
DK2970139T3 (en) 2013-03-15 2018-08-13 Biomarin Pharm Inc HDAC inhibitors
RU2657783C2 (ru) 2013-09-30 2018-06-15 Тайхо Фармасьютикал Ко., Лтд. Комбинированная терапия с использованием азабициклосоединения для ракового заболевания
ES2879294T3 (es) 2016-07-26 2021-11-22 Fresenius Kabi Oncology Ltd Formas polimórficas de Belinostat y procesos para la preparación de las mismas
WO2018213364A1 (en) 2017-05-16 2018-11-22 Annji Pharmaceutical Co., Ltd. Histone deacetylases (hdacs) inhibitors
AU2020404285A1 (en) * 2019-12-16 2022-07-07 Edigene (Guangzhou) Inc. Small molecule compounds for amplifying hematopoietic stem cells, and combination thereof
CN115843292A (zh) 2020-06-08 2023-03-24 安基生技新药股份有限公司 用作选择性hdac6抑制剂的喹唑啉衍生物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
ES2107557T3 (es) 1991-12-10 1997-12-01 Shionogi & Co Derivado de acido hidroxamico a base de sulfonamida aromatica.
AU5886296A (en) * 1995-06-02 1996-12-18 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclo oxygenase-2 and 5-lipoxygenase inhibitors
GB9807354D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
US7141593B1 (en) * 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations
CA2391952C (en) 1999-11-23 2012-01-31 Methylgene Inc. Inhibitors of histone deacetylase
AU2044401A (en) 1999-11-23 2001-06-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
PL367091A1 (en) * 2001-05-22 2005-02-21 Pfizer Products Inc. Crystal forms of azithromycin
CN1551866A (zh) * 2001-08-09 2004-12-01 СҰҩƷ��ҵ��ʽ���� 羧酸衍生物化合物及包含这些化合物为活性成分的药物
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
CA2465978C (en) 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
US6821502B2 (en) * 2002-06-12 2004-11-23 Chevron U.S.A. Inc. Method of making aluminum-containing zeolite with IFR structure
AU2003298567B9 (en) 2002-08-29 2009-07-23 Temple University - Of The Commonwealth System Of Higher Education Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
CA2536954C (en) 2003-08-29 2012-11-27 Exelixis, Inc. C-kit modulators and methods of use
US20080242681A1 (en) 2004-01-22 2008-10-02 Altana Pharma Ag N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
AR047541A1 (es) * 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
JP4856623B2 (ja) 2004-03-11 2012-01-18 フォーエスシー アクチエンゲゼルシャフト 新規のｎ−スルホニルピロール誘導体
US7345043B2 (en) * 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
US7351833B2 (en) * 2004-07-23 2008-04-01 Abbott Laboratories (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
US8436176B2 (en) * 2004-12-30 2013-05-07 Medicis Pharmaceutical Corporation Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
MX2007010561A (es) * 2005-03-15 2008-02-22 Nycomed Gmbh N-sulfonilpirroles y su uso como inhibidores de la histona desacetilasa.
AU2006232773B2 (en) 2005-04-07 2012-04-12 4Sc Ag Sulfonylpyrroles as histone deacetylase inhibitors
UA91546C2 (xx) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-$4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ$КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(b-D-ГЛЮКОПИРАНОЗ-1- ИЛ)-2-$4-((S)- ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ЕЕ ПРИМЕНЕНИЕ ПРИ ПРИГОТАВЛЕНИИ ЛЕКАРСТВЕННЫХ СРЕДСТВ
MY152185A (en) * 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
AU2006285142B2 (en) * 2005-08-29 2012-06-14 Sanofi-Aventis U.S. Llc Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
EP1924592A2 (en) * 2005-09-13 2008-05-28 Sicor, Inc. Process for the synthesis of rocuronium bromide
WO2007039404A1 (en) 2005-09-21 2007-04-12 Nycomed Gmbh Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles
EP2079462A4 (en) * 2006-09-28 2009-12-02 Merck & Co Inc PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHEMABLE COMPOUNDS, AND CHELATED HDAC INHIBITOR METAL COMPLEXES
US7837978B2 (en) * 2006-10-13 2010-11-23 Chevron U.S.A. Inc. Process for preparing aluminum-containing molecular sieve SSZ-26
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
US20090270352A1 (en) * 2007-05-22 2009-10-29 Ultimorphix Technologies B.V. Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
TW200944520A (en) * 2008-01-29 2009-11-01 Glaxo Group Ltd Spiro compounds as NPY Y5 receptor antagonists

Also Published As

Publication number Publication date
US8188138B2 (en) 2012-05-29
EP1928826B1 (en) 2013-04-24
KR101314158B1 (ko) 2013-10-04
EA018698B1 (ru) 2013-10-30
KR20080046730A (ko) 2008-05-27
WO2007039403A1 (en) 2007-04-12
EA200800791A1 (ru) 2009-04-28
IL189781A0 (en) 2008-08-07
CN101287706A (zh) 2008-10-15
BRPI0616040A2 (pt) 2011-06-07
TWI382971B (zh) 2013-01-21
JP2009508825A (ja) 2009-03-05
CA2622670A1 (en) 2007-04-12
US20090297473A1 (en) 2009-12-03
TW200745027A (en) 2007-12-16
NO20081796L (no) 2008-04-17
JP5305909B2 (ja) 2013-10-02
NZ566073A (en) 2011-08-26
AR055647A1 (es) 2007-08-29
EP1928826A1 (en) 2008-06-11
AU2006298881A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
ZA200801351B (en) Sulphonypyrrole hydrochloride salts as histone deacetylases inhibitors
IL188692A0 (en) Histone deacetylase inhibitors
HK1110579A1 (en) New histone deacetylases inhibitors
EP1945617A4 (en) HISTONDEACETYLASEINHIBITORS WITH ARYLPYRAZOLYL MOTIVES
IL205241A0 (en) Histone deacetylase inhibitors
IL193458A0 (en) Histone deacetylase inhibitors
EP2170076A4 (en) 4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONDEACETYLASE INHIBITORS
EP1771167A4 (en) INHIBITORS OF HISTONE DEACETYLASE
HRP20130683T1 (xx) Spojevi benzamida koji su korisni kao inhibitori histonske deacetilaze
EP2049124A4 (en) PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
IL198487A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
EP1991247A4 (en) BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS
EP2049505A4 (en) ISOFORM SELECTIVE HDAC HEMMER
IL198398A0 (en) 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
HK1144070A1 (zh) 肽脫甲酰基酶抑制劑
ZA200806983B (en) Amide derivative or salt thereof
HK1099300A1 (en) Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
IL189112A0 (en) NOVEL HETEROCYCLIC NF-kB INHIBITORS
EP1784386A4 (en) HISTONE DEACETYLASE INHIBITORS
EP1784194A4 (en) HISTONE DEACETYLASE INHIBITORS
EP2205070A4 (en) N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE
EP2231596A4 (en) INHIBITORS OF HISTONATE ACETYLASE
EP2205563A4 (en) NEW HISTONDEACETYLASE INHIBITORS
EP1817020A4 (en) INHIBITORS OF HISTONATE ACETYLASE
GB0700830D0 (en) Crystalline duloxetine hydrochloride